Finance Minister Nirmala Sitharaman on February 1 announced Rs 35,000 crore for the development and manufacturing of COVID-19 vaccines in the Union Budget for the coming year. The Finance Minister added that the expenditure was part of a significantly enhanced outlay on health. Sitharaman said, noting that this was an increase of 137 per cent. Sitharaman also said that two more coronavirus vaccines would be launched. Last month the government approved two vaccines for emergency use in the country. Covishield (developed by pharma giant AstraZeneca and Oxford University, and manufactured by Pune-based Serum Institute) & Covaxin (developed and manufactured by Hyderabad-based Bharat Biotech). Watch the video to know more.